SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Eiko Lifesciences - Quaterly Results

29 Jul 2025 Evaluate
The sales moved down -30.68% to Rs. 74.52 millions for the June 2025 quarter as compared to Rs. 107.50 millions during the corresponding quarter last year.Net profit surges 99.71% to Rs. 6.93  millions  from Rs. 3.47 millions in the quarter ended June 2025.OP of the company witnessed a marginal growth to 10.74 millions from 6.56 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 74.52 107.50 -30.68 74.52 107.50 -30.68 324.92 279.29 16.34
Other Income 5.54 2.62 111.45 5.54 2.62 111.45 10.24 1.76 481.82
PBIDT 10.74 6.56 63.72 10.74 6.56 63.72 27.33 17.88 52.85
Interest 0.18 0.29 -37.93 0.18 0.29 -37.93 1.27 1.42 -10.56
PBDT 10.56 6.27 68.42 10.56 6.27 68.42 29.47 16.46 79.04
Depreciation 1.48 1.65 -10.30 1.48 1.65 -10.30 6.29 6.62 -4.98
PBT 9.08 4.62 96.54 9.08 4.62 96.54 23.18 9.84 135.57
TAX 2.15 1.15 86.96 2.15 1.15 86.96 5.77 2.32 148.71
Deferred Tax 0.16 0.29 -44.83 0.16 0.29 -44.83 1.23 1.34 -8.21
PAT 6.93 3.47 99.71 6.93 3.47 99.71 17.41 7.52 131.52
Equity 137.63 128.73 6.91 137.63 128.73 6.91 137.63 128.73 6.91
PBIDTM(%) 14.41 6.10 136.18 14.41 6.10 136.18 8.41 6.40 31.39

Eiko Lifesciences Share Price

51.51 -1.59 (-2.99%)
10-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
SRF 2732.95
BASF India 3291.00
Tata Chemicals 719.95
Pidilite Inds. 1503.95
Deepak Nitrite 1666.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×